The DOI matches its Crossref record; 386 of the 386 references it cites were found in a registry or an index.
Chemistry, structure and function of approved oligonucleotide therapeutics
Open accessAbstract
Eighteen nucleic acid therapeutics have been approved for treatment of various diseases in the last 25 years. Their modes of action include antisense oligonucleotides (ASOs), splice-switching oligonucleotides (SSOs), RNA interference (RNAi) and an RNA aptamer against a protein. Among the diseases targeted by this new class of drugs are homozygous familial hypercholesterolemia, spinal muscular atrophy, Duchenne muscular dystrophy, hereditary transthyretin-mediated amyloidosis, familial chylomicronemia syndrome, acute hepatic porphyria, and primary hyperoxaluria. Chemical modification of DNA and RNA was central to making drugs out of oligonucleotides. Oligonucleotide therapeutics brought to market thus far contain just a handful of first- and second-generation modifications, among them 2′-fluoro-RNA, 2′-O-methyl RNA and the phosphorothioates that were introduced over 50 years ago. Two other privileged chemistries are 2′-O-(2-methoxyethyl)-RNA (MOE) and the phosphorodiamidate morpholinos (PMO). Given their importance in imparting oligonucleotides with high target affinity, metabolic stability and favorable pharmacokinetic and -dynamic properties, this article provides a review of these chemistries and their use in nucleic acid therapeutics. Breakthroughs in lipid formulation and GalNAc conjugation of modified oligonucleotides have paved the way to efficient delivery and robust, long-lasting silencing of genes. This review provides an account of the state-of-the-art of targeted oligo delivery to hepatocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–386 of 386
Miller, C. M., Donner, A. J., Blank, E. E., Egger, A. W., Kellar, B. M., Østergaard, M. E., Seth, P. P., & Harris, E. N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw112 · Cited by 171
Update review of the acute porphyrias
Stein, P. E., Badminton, M. N., & Rees, D. C. (2017) · British Journal of Haematology · doi:10.1111/bjh.14459 · Cited by 170
Altmann, K.-H., Dean, N. M., Fabbro, D., Freier, S. M., Geiger, T., Häner, R., Hüsken, D., Martin, P., Monia, B. P., Müller, M., et al. (1996) · CHIMIA · doi:10.2533/chimia.1996.168 · Cited by 169
Mechanism of Splicing Regulation of Spinal Muscular Atrophy Genes
Singh, R. N., & Singh, N. N. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_2 · Cited by 167
Delivery is key: lessons learnt from developing splice‐switching antisense therapies
Godfrey, C., Desviat, L. R., Smedsrød, B. H., Piétri‐Rouxel, F., Denti, M. A., Disterer, P., Lorain, S., Nogales‐Gadea, G., Sardone, V., Anwar, R., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607199 · Cited by 166
Crystal structure of a DNA catalyst
Ponce-Salvatierra, A., Wawrzyniak-Turek, K., Steuerwald, U., Höbartner, C., & Peña, V. (2016) · Nature · doi:10.1038/nature16471 · Cited by 165
Dogma Derailed: The Many Influences of RNA on the Genome
Sabin, L. R., Delás, M. J., & Hannon, G. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.010 · Cited by 164
RNA therapy: Are we using the right molecules?
Yu, A.-M., Jian, C., Yu, A. H., & Tu, M.-J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.011 · Cited by 163
Geary, R. S., Yu, R. Z., Watanabe, T., Henry, S. P., Hardee, G. E., Chappell, A., Matson, J., Sasmor, H., Cummins, L., & Levin, A. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1419 · Cited by 162
Structural Foundations of RNA Silencing by Argonaute
Sheu-Gruttadauria, J., & MacRae, I. J. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.07.018 · Cited by 162
Popcorn Polymer as a Support in Multistep Syntheses
Letsinger, R. L., & Kornet, M. J. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00902a054 · Cited by 161
Fomivirsen: Clinical Pharmacology and Potential Drug Interactions
Geary, R. S., Henry, S. P., & Grillone, L. R. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241040-00002 · Cited by 160
DNA phosphorothioation is widespread and quantized in bacterial genomes
Wang, L., Chen, S., Vergin, K. L., Giovannoni, S. J., Chan, S. W., DeMott, M. S., Taghizadeh, K., Cordero, O. X., Cutler, M., Timberlake, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017261108 · Cited by 160
Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy
Salton, M., & Misteli, T. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.11.005 · Cited by 159
The structural diversity of artificial genetic polymers
Anosova, I., Kowal, E. A., Dunn, M. R., Chaput, J. C., Van Horn, W. D., & Egli, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1472 · Cited by 159
Self-citationTargeting RNA : A Transformative Therapeutic Strategy
Yin, W., & Rogge, M. C. (2019) · Clinical and Translational Science · doi:10.1111/cts.12624 · Cited by 159
Lipid nanoparticles for short interfering RNA delivery
Leung, A. K. K., Tam, Y. Y. C., & Cullis, P. R. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00004-3 · Cited by 158
Koonin, E. V. (2017) · Biology Direct · doi:10.1186/s13062-017-0177-2 · Cited by 158
Re-Engineering RNA Molecules into Therapeutic Agents
Egli, M., & Manoharan, M. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.8b00650 · Cited by 158
Self-citationNucleotide chemistry. XX. Phosphite coupling procedure for generating internucleotide links
Letsinger, R. L., Finnan, J. L., Heavner, G. A., & Lunsford, W. B. (1975) · Journal of the American Chemical Society · doi:10.1021/ja00844a090 · Cited by 157
Merki, E., Graham, M. J., Mullick, A. E., Miller, E. R., Crooke, R. M., Pitas, R. E., Witztum, J. L., & Tsimikas, S. (2008) · Circulation · doi:10.1161/circulationaha.108.786822 · Cited by 156
Crystal structure of an RNA aptamer bound to thrombin
Long, S. B., Long, M. B., White, R. R., & Sullenger, B. A. (2008) · RNA · doi:10.1261/rna.1239308 · Cited by 156
High-Resolution Structure of the Eukaryotic 80S Ribosome
Yusupova, G. Z., & Yusupov, M. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035445 · Cited by 156
Friedberg, J. W., Kim, H., McCauley, M., Hessel, E. M., Sims, P. W., Fisher, D. C., Nadler, L. M., Coffman, R. L., & Freedman, A. S. (2004) · Blood · doi:10.1182/blood-2004-06-2156 · Cited by 154
Total chemical synthesis of a 77-nucleotide-long RNA sequence having methionine-acceptance activity.
Ogilvie, K. K., Usman, N., NICOGHOSIAN, K., & Cedergren, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.5764 · Cited by 153
Söll, D. G., Ohtsuka, E., Jones, D. S., Lohrmann, R., Hayatsu, H., Nishimura, S., & Khorana, H. G. (1965) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.54.5.1378 · Cited by 152
Gupta, S., Hirota, M., Waugh, S. M., Murakami, I., Suzuki, T., Muraguchi, M., Shibamori, M., Ishikawa, Y., Jarvis, T. C., Carter, J. D., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532580 · Cited by 151
Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
Fu, Z., & Xiang, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082793 · Cited by 150
Cellular uptake and intracellular trafficking of oligonucleotides
Juliano, R. L., & Carver, K. A. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.005 · Cited by 149
Egli, M., Usman, N., & Rich, A. (1993) · Biochemistry · doi:10.1021/bi00064a004 · Cited by 145
Self-citationα- l -ribo-Configured Locked Nucleic Acid (α-L-LNA): Synthesis and Properties
Sørensen, M. D., Kværnø, L., Bryld, T., Håkansson, A. E., Verbeure, B., Gaubert, G., Herdewijn, P. A., & Wengel, J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0168763 · Cited by 144
DNA phosphorothioate modification—a new multi-functional epigenetic system in bacteria
Wang, L., Jiang, S., Deng, Z., Dedon, P. C., & Chen, S. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy036 · Cited by 144
Pontius, B. W., & Berg, P. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8403 · Cited by 141
Fomivirsen approved for CMV retinitis.
Roehr, B. (1998) · PubMed · Cited by 140
Crystal structure of an RNA aptamer–protein complex at 2.8 Å resolution
Convery, M. A., Rowsell, S., Storehouse, N. J., Ellington, A. D., Hirao, I., Murray, J. B., Peabody, D. S., Phillips, S. E. V., & Stockley, P. G. (1998) · Nature Structural Biology · doi:10.1038/nsb0298-133 · Cited by 137
Wagner, M., Steinbacher, J., Kraus, T. F. J., Michalakis, S., Hackner, B., Pfaffeneder, T., Perera, A., Müller, M., Giese, A., Kretzschmar, H. A., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201502722 · Cited by 136
Mechanistic studies of a small-molecule modulator of SMN2 splicing
Wang, J., Schultz, P. G., & Johnson, K. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800260115 · Cited by 136
Arnold, J. J., Sharma, S. D., Feng, J. Y., Ray, A. S., Smidansky, E. D., Kireeva, M. L., Cho, A., Perry, J. K., Vela, J. E., Park, Y., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003030 · Cited by 135
Duell, P. B., Santos, R. D., Kirwan, B., Witztum, J. L., Tsimikas, S., & Kastelein, J. J. P. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.04.013 · Cited by 134
Cheung, A. K., Hurley, B., Kerrigan, R., Shu, L., Chin, D. N., Shen, Y., O’Brien, G., Sung, M. J., Hou, Y., Axford, J., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01291 · Cited by 134
Nucleotide chemistry. XIII. Synthesis of oligothymidylates via phosphotriester intermediates
Letsinger, R. L., & Ogilvie, K. K. (1969) · Journal of the American Chemical Society · doi:10.1021/ja01040a042 · Cited by 133
Crooke, S. T., Baker, B. F., Kwoh, T. J., Cheng, W., Schulz, D. J., Xia, S., Salgado, N. R., Bui, H., Hart, C. E., Burel, S. A., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.136 · Cited by 133
Sano, M., Sierant, M., Miyagishi, M., Nakanishi, M., Takagi, Y., & Sutou, S. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn584 · Cited by 132
Willoughby, J. L. S., Chan, A., Sehgal, A., Butler, J. S., Nair, J. K., Racie, T., Shulga‐Morskaya, S., Nguyen, T. M., Qian, K., Yucius, K., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.08.019 · Cited by 130
Self-citationCrooke, S. T., Baker, B. F., Witztum, J. L., Kwoh, T. J., Pham, N. C., Salgado, N., McEvoy, B. W., Cheng, W., Hughes, S. G., Bhanot, S., et al. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2016.0650 · Cited by 129
Griffey, R. H., Monia, B. P., Cummins, L. L., Freier, S. M., Greig, M. J., Guinosso, C. J., Lesnik, E. A., Manalili, S. M., Mohan, V., Owens, S. R., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950937o · Cited by 128
Chang, C. I., Yoo, J. W., Hong, S. W., Lee, S. E., Kang, H. S., Sun, X., Rogoff, H. A., Ban, C., Kim, S., Li, C. J., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2008.298 · Cited by 128
Hodgson, J. (2020) · Nature Biotechnology · doi:10.1038/d41587-020-00005-z · Cited by 128
Ferreira‐Bravo, I. A., Cozens, C., Holliger, P., & DeStefano, J. J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1057 · Cited by 124
Asymmetric RNA duplexes mediate RNA interference in mammalian cells
Sun, X., Rogoff, H. A., & Li, C. J. (2008) · Nature Biotechnology · doi:10.1038/nbt.1512 · Cited by 123
Evoking picomolar binding in RNA by a single phosphorodithioate linkage
Abeydeera, N., Egli, M., Cox, N., Mercier, K., Conde, J. N., Pallan, P. S., Mizurini, D. M., Sierant, M., Hibti, F.-E., Hassell, T., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw725 · Cited by 122
Self-citationAntisense antimicrobial therapeutics
Sully, E. K., & Geller, B. L. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.05.017 · Cited by 120
Generating Biologically Stable TNA Aptamers that Function with High Affinity and Thermal Stability
Dunn, M. R., McCloskey, C. M., Buckley, P. E., Rhea, K. A., & Chaput, J. C. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c00641 · Cited by 120
Kasuya, T., Hori, S.-I., Watanabe, A., Nakajima, M., Gahara, Y., Rokushima, M., Yanagimoto, T., & Kugimiya, A. (2016) · Scientific Reports · doi:10.1038/srep30377 · Cited by 119
Feng, B., Sosa, R. P., Mårtensson, A. K. F., Jiang, K., Tong, A., Dorfman, K. D., Takahashi, M., Lincoln, P., Bustamante, C., Westerlund, F., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909122116 · Cited by 119
Berger, I., Tereshko, V. A., Ikeda, H., Márquez, V. E., & Egli, M. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.10.2473 · Cited by 118
Self-citationLima, W. F., & Crooke, S. T. (1997) · Biochemistry · doi:10.1021/bi962230p · Cited by 117
Eckstein, F. (1966) · Journal of the American Chemical Society · doi:10.1021/ja00970a054 · Cited by 116
Lubini, P., Zürcher, W., & Egli, M. (1994) · Chemistry & Biology · doi:10.1016/1074-5521(94)90039-6 · Cited by 114
Self-citationTissue Disposition of 2′‐O‐(2‐methoxy) ethyl Modified Antisense Oligonucleotides in Monkeys
Yu, R. Z., Geary, R. S., Monteith, D., Matson, J. E., Truong, L., Fitchett, J. R., & Levin, A. A. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10473 · Cited by 114
ALTMANN, K. ‐., Fabbro, D., Dean, N. M., et al. (1996) · Biochemical Society Transactions · doi:10.1042/bst0240630 · Cited by 114
Selective tissue targeting of synthetic nucleic acid drugs
Seth, P. P., Tanowitz, M., & Bennett, C. F. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125228 · Cited by 114
Tereshko, V. A., Gryaznov, S. M., & Egli, M. (1998) · Journal of the American Chemical Society · doi:10.1021/ja971962h · Cited by 112
Self-citationEckstein, F. (1970) · Journal of the American Chemical Society · doi:10.1021/ja00718a039 · Cited by 111
Schlegel, M. K., Janas, M. M., Jiang, Y., Barry, J. D., Davis, W. P., Agarwal, S., Berman, D., Brown, C. R., Castoreno, A. B., LeBlanc, S., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac539 · Cited by 110
Self-citationOligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro
Bell, C., Lynam, E. B., Landfair, D. J., Janjić, N., & Wiles, M. E. (1999) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-999-0064-y · Cited by 109
Rich, A. S. (1960) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.46.8.1044 · Cited by 109
Egli, M., Minasov, G., Tereshko, V. A., Pallan, P. S., Teplova, M., Inamati, G. B., Lesnik, E. A., Owens, S. R., Ross, B. S., Prakash, T. P., et al. (2005) · Biochemistry · doi:10.1021/bi050574m · Cited by 109
Self-citationSanhueza, C., Baksh, M. M., Thuma, B. A., Roy, M. D., Dutta, S., Préville, C., Chrunyk, B. A., Beaumont, K. C., Dullea, R., Ammirati, M. J., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b12964 · Cited by 109
Sequence and Structural Conservation in RNA Ribose Zippers
Tamura, M., & Holbrook, S. R. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00515-6 · Cited by 108
Angiozyme: A Novel angiogenesis inhibitor
Weng, D. E., & Usman, N. (2001) · Current Oncology Reports · doi:10.1007/s11912-001-0014-7 · Cited by 107
Crystal structures of a series of RNA aptamers complexed to the same protein target
Rowsell, S., Stonehouse, N. J., Convery, M. A., Adams, C. J., Ellington, A. D., Hirao, I., Peabody, D. S., Stockley, P. G., & Phillips, S. E. V. (1998) · Nature Structural Biology · doi:10.1038/2946 · Cited by 106
Pharmacokinetics and Tissue Distribution of a Peptide Nucleic Acid After Intravenous Administration
McMahon, B. M., Mays, D. C., Lipsky, J. J., Stewart, J. A., Fauq, A. H., & Richelson, E. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760070803 · Cited by 106
Nusinersen for spinal muscular atrophy
Wurster, C. D., & Ludolph, A. C. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285618754459 · Cited by 104
Phillips, J. A., Craig, S. J., Bayley, D., Christian, R. A., Geary, R., & Nicklin, P. L. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00190-1 · Cited by 103
Anzahaee, M. Y., Watts, J. K., Alla, N. R., Nicholson, A. W., & Damha, M. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja109817p · Cited by 102
RNA Folds: Insights from Recent Crystal Structures
Ferré-D’Amaré, A. R., & Doudna, J. A. (1999) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.28.1.57 · Cited by 102
Hyjek‐Składanowska, M., Vickers, T. A., Napiórkowska-Gromadzka, A., Anderson, B. A., Tanowitz, M., Crooke, S. T., Liang, X., Seth, P. P., & Nowotny, M. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b13524 · Cited by 102
Patra, A., Paolillo, M., Charissé, K., Manoharan, M., Rozners, E., & Egli, M. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201204946 · Cited by 101
Self-citationSkipping Multiple Exons to Treat DMD—Promises and Challenges
Aslesh, T., Maruyama, R., & Yokota, T. (2018) · Biomedicines · doi:10.3390/biomedicines6010001 · Cited by 100
Prakash, T. P., Lima, W. F., Murray, H. M., Li, W., Kinberger, G. A., Chappell, A. E., Gaus, H. J., Seth, P. P., Bhat, B., Crooke, S. T., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv162 · Cited by 99
Oral delivery of non-viral nucleic acid-based therapeutics - do we have the guts for this?
O’Driscoll, C. M., Bernkop‐Schnürch, A., Friedl, J. D., Véronique Préat, A., & Jannin, V. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.03.027 · Cited by 99
Geary, R. S., Leeds, J. M., Fitchett, J. R., et al. (1997) · PubMed · Cited by 98
Mechanism of N-Acetylgalactosamine Binding to a C-type Animal Lectin Carbohydrate-recognition Domain
Kolatkar, A. R., Leung, A. K. L., Isecke, R., Brossmer, R., Drickamer, K., & Weis, W. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.31.19502 · Cited by 97
Koziołkiewicz, M., Wójcik, M., Kobylańska, A., Karwowski, B. T., Rębowska, B., Guga, P., & Stec, W. J. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.43 · Cited by 96
A Single 2′-Hydroxyl Group Converts B-DNA to A-DNA
Ban, C., Ramakrishnan, B., & Sundaralingam, M. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1134 · Cited by 95
Skabkin, M. A., Evdokimova, V. E., Thomas, A. A. M., & Ovchinnikov, L. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107581200 · Cited by 93
Structural Analysis of Human Argonaute-2 Bound to a Modified siRNA Guide
Schirle, N. T., Kinberger, G. A., Murray, H. F., Lima, W. F., Prakash, T. P., & MacRae, I. J. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b04454 · Cited by 92
Elkayam, E., Parmar, R. G., Brown, C. R., Willoughby, J. L. S., Theile, C. S., Manoharan, M., & Joshua‐Tor, L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1171 · Cited by 92
Self-citationStrunecká, A., Patočka, J., & Connett, P. H. (2004) · Journal of Applied Biomedicine · doi:10.32725/jab.2004.017 · Cited by 91
Schlegel, M. K., Foster, D. J., Kel’in, A. V., Zlatev, I., Bisbe, A., Jayaraman, M., Lackey, J. G., Rajeev, K. G., Charissé, K., Harp, J. M., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b02694 · Cited by 91
Self-citationInotersen: new promise for the treatment of hereditary transthyretin amyloidosis
Mathew, V., & Wang, A. K. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s162913 · Cited by 91
Gales, L. (2019) · Pharmaceuticals · doi:10.3390/ph12020078 · Cited by 90
Occurrence, evolution, and functions of DNA phosphorothioate epigenetics in bacteria
Tong, T., Chen, S., Wang, L., Tang, Y., Ryu, J. Y., Jiang, S., Wu, X., Chen, C., Luo, J., Deng, Z., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721916115 · Cited by 89
Phosphodiester models for cleavage of nucleic acids
Mikkola, S., Lönnberg, T., & Lönnberg, H. (2018) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.14.68 · Cited by 89
Senn, J. J., Burel, S. A., & Henry, S. P. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084004 · Cited by 88
Safety evaluation of 2′-deoxy-2′-fluoro nucleotides in GalNAc-siRNA conjugates
Janas, M. M., Zlatev, I., Liu, J., Jiang, Y., Barros, S. A., Sutherland, J. E., Davis, W. P., Liu, J., Brown, C. R., Liu, X., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz140 · Cited by 88
Self-citationAn Exocyclic Methylene Group Acts As a Bioisostere of the 2′-Oxygen Atom in LNA
Seth, P. P., Allerson, C. R., Berdeja, A., Siwkowski, A. M., Pallan, P. S., Gaus, H. J., Prakash, T. P., Watt, A. T., Egli, M., & Swayze, E. E. (2010) · Journal of the American Chemical Society · doi:10.1021/ja105875e · Cited by 86
Self-citationAlagia, A., & Eritja, R. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1337 · Cited by 86
A new type of DNA phosphorothioation-based antiviral system in archaea
Xiong, L., Liu, S., Chen, S., Xiao, Y., Zhu, B., Gao, Y., Zhang, Y., Chen, B., Luo, J., Deng, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09390-9 · Cited by 84
Challenges and Opportunities for Nucleic Acid Therapeutics
Corey, D. R., Damha, M. J., & Manoharan, M. (2021) · Nucleic Acid Therapeutics · doi:10.1089/nat.2021.0085 · Cited by 84
Self-citationLima, W. F., Nichols, J. G., Wu, H., Prakash, T. P., Migawa, M. T., Wyrzykiewicz, T. K., Bhat, B., & Crooke, S. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405035200 · Cited by 83
Dolot, R., Lam, C. H., Sierant, M., Zhao, Q., Liu, F., Nawrot, B., Egli, M., & Yang, X. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky268 · Cited by 83
Self-citationAird, D. R., Teng, T., Huang, C. L., Pazolli, E., Banka, D., Cheung-Ong, K., Eifert, C., Furman, C., Wu, Z. J., Seiler, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08150-5 · Cited by 83
Murray, S., Ittig, D., Koller, E., Berdeja, A., Chappell, A., Prakash, T. P., Norrbom, M., Swayze, E., Leumann, C., & Seth, P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks273 · Cited by 82
Structural origins of the exonuclease resistance of a zwitterionic RNA
Teplova, M., Wallace, S. T., Tereshko, V. A., Minasov, G., Symons, A. M., Cook, P. D., Manoharan, M., & Egli, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14240 · Cited by 81
Self-citationBobst, A. M., ROTTMAN, F. M., & Cerutti, P. (1969) · Journal of Molecular Biology · doi:10.1016/0022-2836(69)90418-5 · Cited by 80
Pallan, P. S., Allerson, C. R., Berdeja, A., Seth, P. P., Swayze, E. E., Prakash, T. P., & Egli, M. (2012) · Chemical Communications · doi:10.1039/c2cc32286b · Cited by 79
Self-citationAdjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade
Chuang, Y.-C., Tseng, J., Huang, L.-R., Huang, C., Huang, C. F., & Chuang, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01075 · Cited by 79
Structure of the Dicer-2–R2D2 heterodimer bound to a small RNA duplex
Yamaguchi, S., Naganuma, M., Nishizawa, T., Kusakizako, T., Tomari, Y., Nishimasu, H., & Nureki, O. (2022) · Nature · doi:10.1038/s41586-022-04790-2 · Cited by 77
Onasemnogene abeparvovec for spinal muscular atrophy: The costlier drug ever
Mahajan, R. (2019) · International Journal of Applied and Basic Medical Research · doi:10.4103/ijabmr.ijabmr_190_19 · Cited by 76
PNAzymes That Are Artificial RNA Restriction Enzymes
Murtola, M., Wenska, M., & Strömberg, R. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1008739 · Cited by 74
Vincent van Gogh's illness: acute intermittent porphyria?
Loftus, L., & Arnold, W. N. (1991) · BMJ · doi:10.1136/bmj.303.6817.1589 · Cited by 74
Crystal structure of an Okazaki fragment at 2-A resolution.
Egli, M., Usman, N., Zhang, S., & Rich, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.534 · Cited by 72
Self-citationSynthesis and biological applications of fluoro-modified nucleic acids
Guo, F., Li, Q., & Zhou, C. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob02094e · Cited by 70
The Effects of 2′- O -Methoxyethyl Oligonucleotides on Renal Function in Humans
Crooke, S. T., Baker, B. F., Pham, N. C., Hughes, S. G., Kwoh, T. J., Cai, D., Tsimikas, S., Geary, R. S., & Bhanot, S. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0693 · Cited by 69
Grillone, L. R., & Lanz, R. (2001) · Drugs of today · doi:10.1358/dot.2001.37.4.620590 · Cited by 69
A Status Update of Modified Oligonucleotides for Chemotherapeutics Applications
Sanghvi, Y. S. (2011) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc0401s46 · Cited by 67
The potential of 1018 ISS adjuvant in hepatitis B vaccines
Eng, N. F., Bhardwaj, N., Mulligan, R., & Díaz‐Mitoma, F. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24715 · Cited by 65
Zhang, J., Harvey, S. E., & Cheng, C. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz036 · Cited by 65
Denisov, A. Y. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.21.4284 · Cited by 61
Structure and Formation of Z-DNA and Z-RNA
Krall, J. B., Nichols, P. J., Henen, M. A., Vicens, Q., & Vögeli, B. (2023) · Molecules · doi:10.3390/molecules28020843 · Cited by 61
Yu, R. Z., Geary, R. S., Leeds, J. M., Watanabe, T. A., Moore, M., Fitchett, J. R., Matson, J. E., Burckin, T., Templin, M. V., & Levin, A. A. (2001) · Journal of Pharmaceutical Sciences · Cited by 60
Synthesis of 2'-O-Methyluridine, 2'-O-Methylcytidine and Their Relating Compounds.
Furukawa, Y., Kobayashi, K., Kanai, Y., & Honjo, M. (1965) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.13.1273 · Cited by 60
RNase H sequence preferences influence antisense oligonucleotide efficiency
Kielpinski, L. J., Hagedorn, P., Lindow, M., & Vinther, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1073 · Cited by 60
In silico selection of active siRNA
Patzel, V. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.015 · Cited by 59
Li, F., Sarkhel, S., Wilds, C. J., Wawrzak, Z., Prakash, T. P., Manoharan, M., & Egli, M. (2006) · Biochemistry · doi:10.1021/bi052322r · Cited by 59
Self-citationPhosphorothioate Oligonucleotides Inhibit the Intrinsic Tenase Complex by an Allosteric Mechanism
Sheehan, J. P., & Phan, T. M. (2001) · Biochemistry · doi:10.1021/bi002396x · Cited by 58
Parmar, R. G., Brown, C. R., Matsuda, S., Willoughby, J. L. S., Theile, C. S., Charissé, K., Foster, D. J., Zlatev, I., Jadhav, V., Maier, M. A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01147 · Cited by 58
Self-citationInfluence of the 2′-Hydroxyl Group Conformation on the Stability of A-form Helices in RNA
Fohrer, J., Hennig, M., & Carlomagno, T. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.043 · Cited by 56
Structure of the Parallel Duplex of Poly(A) RNA: Evaluation of a 50 Year‐Old Prediction
Safaee, N., Noronha, A. M., Rodionov, D., Kozlov, G., Wilds, C. J., Sheldrick, G. M., & Gehring, K. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201303461 · Cited by 55
Human DNA polymerase η has reverse transcriptase activity in cellular environments
Su, Y. R., Ghodke, P. P., Egli, M., Li, L., Wang, Y., & Guengerich, F. P. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007925 · Cited by 55
Self-citationCleavage of double-stranded RNA by RNase HI from a thermoacidophilic archaeon, Sulfolobus tokodaii 7
Ohtani, N., Yanagawa, H., Tomita, M., & Itaya, M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh917 · Cited by 54
Invention and Early History of Morpholinos: From Pipe Dream to Practical Products
Summerton, J. E. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6817-6_1 · Cited by 51
Mechanism of Ribonucleotide Incorporation by Human DNA Polymerase η
Su, Y. R., Egli, M., & Guengerich, F. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.706226 · Cited by 50
Self-citationYazbeck, D. R., Min, K.-L., & Damha, M. J. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf429 · Cited by 45
Butler, M., Hayes, C. S., Chappell, A. E., Murray, S., Yaksh, T. L., & Hua, X. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.11.038 · Cited by 44
Mutisya, D., Hardcastle, T., Cheruiyot, S. K., Pallan, P. S., Kennedy, S. D., Egli, M., Kelley, M. L., Smith, A. V. B., & Rozners, E. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx558 · Cited by 43
Self-citationHuman DNA polymerase η accommodates RNA for strand extension
Su, Y. R., Egli, M., & Guengerich, F. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.809723 · Cited by 43
Self-citationBaek, M.-S., Yu, R. Z., Gaus, H. J., Grundy, J. S., & Geary, R. S. (2010) · Oligonucleotides · doi:10.1089/oli.2010.0252 · Cited by 42
siRNA drug Leqvio (inclisiran) to lower cholesterol
Migliorati, J. M., Jin, J., & Zhong, X. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.02.003 · Cited by 41
Vickers, T. A., Lima, W. F., Wu, H., Nichols, J. G., Linsley, P. S., & Crooke, S. T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp735 · Cited by 40
Lima, W. F., Rose, J. B., Nichols, J. G., Wu, H., Migawa, M. T., Wyrzykiewicz, T. K., Vasquez, G., Swayze, E. E., & Crooke, S. T. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025429 · Cited by 39
Schlegel, M. K., Matsuda, S., Brown, C. R., Harp, J. M., Barry, J. D., Berman, D., Castoreno, A. B., Schofield, S., Szeto, J., Manoharan, M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab916 · Cited by 39
Self-citationEgli, M. (2012) · Accounts of Chemical Research · doi:10.1021/ar200303k · Cited by 38
Self-citationTherapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis
Niemietz, C., Chandhok, G., & Schmidt, H. (2015) · Molecules · doi:10.3390/molecules201017944 · Cited by 37
Targeting Therapeutic Oligonucleotides
Levin, A. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmcibr1613559 · Cited by 37
5′-Morpholino modification of the sense strand of an siRNA makes it a more effective passenger
Kumar, P., Parmar, R. G., Brown, C. R., Willoughby, J. L. S., Foster, D. J., Babu, I. R., Schofield, S., Jadhav, V., Charissé, K., Nair, J. K., et al. (2019) · Chemical Communications · doi:10.1039/c9cc00977a · Cited by 37
Self-citationIntrinsic contribution of the 2′-hydroxyl to RNA conformational heterogeneity
Denning, E. J., & MacKerell, A. D. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211328g · Cited by 36
Zhao, X., Feng, Z., Ling, K., Mollin, A., Sheedy, J., Yeh, S., Petruska, J. M., Narasimhan, J., Dakka, A., Welch, E. M., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw062 · Cited by 36
In Gratitude for mRNA Vaccines
Stuart, L. M. (2021) · New England Journal of Medicine · doi:10.1056/nejmcibr2111445 · Cited by 36
Discovery of the Hybrid Helix and the First DNA-RNA Hybridization
Rich, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.x600003200 · Cited by 35
Koonin, E. V. (2014) · Antonie van Leeuwenhoek · doi:10.1007/s10482-014-0169-5 · Cited by 34
Bhadra, J., Pattanayak, S., & Sinha, S. (2015) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc0465s62 · Cited by 33
Harchaoui, K. E., Akdim, F., Stroes, E. S. G., Trip, M. D., & Kastelein, J. J. P. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200808040-00003 · Cited by 32
Pallan, P. S., & Egli, M. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6461 · Cited by 32
Self-citationThe many twists and turns of DNA: template, telomere, tool, and target
Egli, M., & Pallan, P. S. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2010.03.001 · Cited by 31
Self-citationRNase H sequence preferences influence antisense oligonucleotide efficiency
Kielpinski, L. J., Hagedorn, P., Lindow, M., & Vinther, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz065 · Cited by 31
Hardcastle, T., Novosjolova, I., Kotikam, V., Cheruiyot, S. K., Mutisya, D., Kennedy, S. D., Egli, M., Kelley, M. L., Smith, A. V. B., & Rozners, E. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b01012 · Cited by 30
Self-citationNicklin, P. L., Craig, S. J., & Phillips, J. A. (1998) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58785-6_4 · Cited by 29
The RNA World: 4,000,000,050 years old
Lehman, N. (2015) · Life · doi:10.3390/life5041583 · Cited by 27
Strategies to Avoid Artifacts in Mass Spectrometry‐Based Epitranscriptome Analyses
Kaiser, S., Byrne, S. R., Ammann, G., Atoi, P. A., Borland, K. M., Brecheisen, R., DeMott, M. S., Gehrke, T., Hagelskamp, F., Heiß, M., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202106215 · Cited by 27
Egli, M., & Lybrand, T. P. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b00104 · Cited by 26
Self-citationAsymmetric siRNA: New Strategy to Improve Specificity and Reduce Off-Target Gene Expression
Yuan, Z., Wu, X., Liu, C., Xu, G., & Wu, Z. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.145 · Cited by 25
Elkhalifa, D. H., Rayan, M., Negmeldin, A. T., Elhissi, A. M. A., & Khalil, A. A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112385 · Cited by 24
Selective Modulation of DNA Polymerase Activity by Fixed‐Conformation Nucleoside Analogues
Eoff, R. L., McGrath, C. E., Maddukuri, L., Salamanca-Pinzon, S. G., Márquez, V. E., Marnett, L. J., Guengerich, F. P., & Egli, M. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201003168 · Cited by 23
Self-citationDiscovering the RNA Double Helix and Hybridization
Varshavsky, A. J. (2006) · Cell · doi:10.1016/j.cell.2006.12.008 · Cited by 22
Yamasaki, K., Akutsu, Y., Yamasaki, T., Miyagishi, M., & Kubota, T. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa170 · Cited by 22
Pallan, P. S., Prakash, T. P., Li, F., Eoff, R. L., Manoharan, M., & Egli, M. (2009) · Chemical Communications · doi:10.1039/b822781k · Cited by 21
Self-citationActivating frataxin expression by single-stranded siRNAs targeting the GAA repeat expansion
Shen, X., Kilikevičius, A., O’Reilly, D., Prakash, T. P., Damha, M. J., Rigo, F., & Corey, D. R. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.07.033 · Cited by 21
Wada, S., Obika, S., Shibata, M., Yamamoto, T., Nakatani, M., Yamaoka, T., Torigoe, H., & Harada‐Shiba, M. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.32 · Cited by 20
Koch, T. (2013) · Current Physical Chemistry · doi:10.2174/1877946811303010009 · Cited by 20
Akabane‐Nakata, M., Erande, N. D., Kumar, P., Degaonkar, R., Gilbert, J. A., Qin, J., Mendez, M., Woods, L. B., Jiang, Y., Janas, M. M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab050 · Cited by 20
Self-citationVivo, D. C. D., Hwu, W., Reyna, S. P., Farwell, W. R., Gheuens, S., Sun, P., Zhong, Z. J., Su, J. Q., Schneider, E., & Bertini, E. (2017) · Neurology · doi:10.1212/wnl.88.16_supplement.s46.003 · Cited by 19
Single-Stranded Silencing RNAs: Hit Rate and Chemical Modification
Pendergraff, H. M., Debacker, A. J., & Watts, J. K. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0557 · Cited by 17
Pallan, P. S., Prakash, T. P., de Leon, A. R., & Egli, M. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00849 · Cited by 16
Self-citationLumasiran: expanding the treatment options for patients with primary hyperoxaluria type 1
Hulton, S. (2021) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2021.2003779 · Cited by 16
Won, J. I., Zhang, J., & McCullough, P. A. (2017) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0834 · Cited by 13
Unnatural Nucleoside Analogs for Antisense Therapy
Seth, P. P., & Swayze, E. E. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527676545.ch12 · Cited by 12
Egli, M. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781837671328-00020 · Cited by 10
Self-citationTowards the structure-based design of oligonucleotide therapeutics
Egli, M. (1998) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(97)00004-6 · Cited by 9
Self-citationMorrell, N. W. (2010) · Oxford University Press eBooks · doi:10.1093/med/9780199204854.003.161501 · Cited by 8
Sugar Pucker and Nucleic Acid Structure
Egli, M. (2018) · doi:10.1142/9789813272682_others05 · Cited by 8
Self-citationPREDICTION OF ANTISENSE OLIGONUCLEOTIDE EFFICACY USING AGGREGATE MOTIFS
Sipes, T., & Freier, S. M. (2008) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720008003795 · Cited by 6
transcription factor SATB1 CUTr1 domain in complex with a phosphorothioate DNA
Akutsu, Y., Kubota, T., Yamasaki, T., & Yamasaki, K. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6lff/pdb · Cited by 6
Ketkar, A. D., Zafar, M. K., Banerjee, S., et al. (2012) · Biochemistry · doi:10.1021/bi301043k · Cited by 5
Cited by
Epigenetics-targeted drugs: current paradigms and future challenges
Dai, W., Qiao, X., Fang, Y., Guo, R., Bai, P., Liu, S., Li, T., Jiang, Y., Wei, S., Na, Z., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02039-0 · Cited by 339
RNAi-based drug design: considerations and future directions
Tang, Q., & Khvorova, A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00912-9 · Cited by 282
Lauffer, M. C., van Roon-Mom, W., Aartsma-Rus, A., & Collaborative, N. =. 1. (2024) · Communications Medicine · doi:10.1038/s43856-023-00419-1 · Cited by 273
Sorets, A. G., Schwensen, K. R., Francini, N., Kjar, A., Abdulrahman, A. M., Shostak, A., Katdare, K. A., Schoch, K. M., Cowell, R. P., Park, J. C., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf600 · Cited by 6
“The development of precise therapeutic modalities such as short interfering RNA (siRNA) has expanded the toolbox of medicines to correct disease-driving defects, as evidenced by the recent FDA approval of GalNAc conjugates that act in the liver [ 1 ].”
Sorets, A., Schwensen, K., Francini, N., Kjar, A., Abdulrahman, A., Shostak, A., Katdare, K., Schoch, K., Cowell, R., Park, J., et al. (2024) · doi:10.1101/2024.06.09.598079 · Cited by 4
Metadata
- Authors
- Egli, M., & Manoharan, M.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-03-07
- Volume
- 51
- Issue
- 6
- Pages
- 2529-2573
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W4323352404
- Cited by
- 828
- References
- 386
- FWCI
- 62.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.